PGE2-mediated cytoprotection in renal epithelial cells: Evidence for a pharmacologically distinct receptor

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 4 42-4, 1997, Pages

  Weber, Thomas J ^a   Monks, Terrence J ^a   Lau, Serrine S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

E prostanoid receptor; Kidney; Protein kinase C; Quinone thioether

Indexed keywords

HYDROQUINONE DERIVATIVE; PROSTAGLANDIN E2; 16,16 DIMETHYLPROSTAGLANDIN E2; 2,3,5 (TRIGLUTATHION S YL)HYDROQUINONE; 2,3,5-(TRIGLUTATHION-S-YL)HYDROQUINONE; DRUG DERIVATIVE; GLUTATHIONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E RECEPTOR; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CYTOPATHOGENIC EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL STRAIN; CLASSIFICATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; KIDNEY; METABOLISM; PHYSIOLOGY; SWINE;

16,16-DIMETHYLPROSTAGLANDIN E2; ANIMALS; CYTOPROTECTION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLUTATHIONE; HYDROQUINONES; KIDNEY; LLC-PK1 CELLS; PROTEIN KINASE C; RECEPTORS, PROSTAGLANDIN E; SWINE; TETRADECANOYLPHORBOL ACETATE;

EID: 0030683545     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.4.f507     Document Type: Article

References (37)

1. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663: 237-243, 1994.
2. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. Imbra, H. Rahmsdorf, C. Jonat, P. Herrlisch, and M. Karin. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739, 1987.
3. Angel, P., K. Hattori, T. Smeal, and M. Karin. The Jun protooncogene is positively autoregulated by its product, Jun/ AP1. Cell 55: 875-885, 1988.
4. Asaoka, Y., S. Nakamura, K. Yoshida, and Y. Nishizuka. Protein kinase C, calcium and phospholipid degradation. Trends Biochem. Sci. 17: 414-417, 1992.
5. 2 subtype. J. Biol. Chem. 269: 11873-11877, 1994.
6. Bowes, R. C., III, T. J. Weber, and K. S. Ramos. Induction of highly proliferative phenotypes in cultured glomerular mesangial cells by benzo[a]pyrene alone or in combination with methoxamine. Arch. Biochem. Biophys. 323: 243-250, 1995.
7. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
8. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]5-isoquinoline sulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272, 1990.
9. Cohen, M. M. The arachidonic acid cascade. In: Biological Protection with Prostaglandins, edited by M. M. Cohen. Boca Raton, FL: CRC, 1985, p. 3-12.
10. Coleman, R. A., S. A. Grix, J. B. Head, J. B. Louttit, A. Mallett, and R. L. G. Sheldrick. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47: 151-168, 1994.
11. 2-sensitive (EP) receptors. In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research, edited by B. Samuelsson, R. Paoletti, and P. W. Ramwell. New York: Raven, 1987, vol. 17, p. 467-470.
12. Coleman, R. A., W. L. Smith, and S. Narumiya. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
13. Downie, W. W. Prostaglandins and NSAID in the kidney. J. Rheumatol. 18: 19-21, 1991.
14. 1 subtype. J. Biol. Chem. 268: 26767-26772, 1993.
15. 2: the reason for low assay reliability. Prostaglandins 19: 933-957, 1980.
16. Guth, P. H., G. Paulsen, and K. Hirabayashi. Prostaglandin cytoprotection. Prostaglandin does not protect against aspirin-or alcohol-induced acute red blood cell hemolysis. Dig. Dis. Sci. 28: 903-907, 1983.
17. Hebert, R. L., R. M. Breyer, H. R. Jacobson, and M. D. Breyer. Functional and molecular aspects of prostaglandin E receptors in the cortical collecting duct. Can. J. Physiol. Pharmacol. 73: 172-179, 1995.
18. 2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F643-F650, 1993.
19. 3 in frog tissue. J. Chromatogr. Sci. 394: 353-362, 1987.
20. Hill, B. A., H. E. Kleiner, E. A. Ryan, D. M. Dulik, T. J. Monks, and S. S. Lau. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Chem. Res. Toxicol. 6: 459-469, 1993.
21. Hirata, M., and K. Ohno. Effect of cyclopentenone prostaglandins on glutathione biosynthesis. In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research, edited by B. Samuelsson, R. Paoletti, and P. W. Ramwell. New York: Raven, 1990, vol. 21, p. 859-862.
22. Karin, M. Signal Transduction from cell surface to nucleus in development and desease. FASEB J. 6: 2581-2590, 1992.
23. Karin, M., and T. Smeal. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17: 418-422, 1992.
24. Lau, S. S., B. A. Hill, R. J. Highet, and T. J. Monks. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 34: 829-836, 1988.
25. 2 on oxygen uptake and microcirculation in the perfused rat liver. Hepatology 6: 917-921, 1986.
26. Mertens, J. J. W. M., N. W. Gibson, S. S. Lau, and T. J. Monks. Reactive oxygen species and DNA damage in 2-bromo-(glutathion-S-yl) hydroquinone-mediated cytotoxicity. Arch. Biochem. Biophys. 320: 51-58, 1995.
27. Moore, P. K. Prostanoids and the kidney. In: Prostanoids: Pharmacological, Physiological and Clinical Relevance, edited by P. K. Moore. New York: Cambridge Univ. Press, 1985, p. 173-199.
28. Nishizuka, Y. Intracellular signaling by hydrolosis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
29. Olson, E. N., R. Burgess, and J. Staudinger. Protein kinase C as a transducer of nuclear signals. Cell Growth Differ. 4: 699-705, 1993.
30. Paller, M. S., and J. C. Manivel. Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int. 42: 1345-1354, 1992.
31. Pierce, K. L., D. W. Gil, D. F. Woodward, and J. W. Regan. Cloning of human prostanoid receptors. Trends Pharmacol. Sci. 16: 253-256, 1995.
32. Robert, A. Cytoprotection by prostaglandins. Gastroenterology 77: 761-767, 1979.
33. 2 and fatty acids protect hepatocytes against CC14-induced damage. In Vitro Cell. Dev. Biol. 21: 450-452, 1985.
34. Schlondorff, D. Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am. J. Med. 81: 1-11, 1986.
35. 3 subtype. J. Biol. Chem. 267: 6463-6466, 1992.
36. 2 potentiates platelet aggregation by priming protein kinase C. Blood 82: 2704-2713, 1993.
37. Weber, T. J., R. S. Chapkin, L. A. Davidson, and K. S. Ramos. Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence. Arch. Biochem. Biophys. 328: 227-232, 1996.